MELBOURNE, Australia (AP) — Australian accident investigators on Thursday released dramatic images of a skydiver’s parachute becoming entangled on an airplane’s tail, leaving him dangling at 15,000 ...

Video released by Australia’s transport safety agency on Thursday shows the harrowing moment when a skydiver’s parachute was caught on the tail of an airplane before a jump in September. According to ...

James is a published author with multiple pop-history and science books to his name. He specializes in history, space, strange science, and anything out of the ordinary.View full profile James is a ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Plume, a real world asset (RWA)-focused blockchain project, has debuted its Nest yield vaults directly on Solana, giving the network’s users native access to institutional-grade real-world assets for ...

User acquisition budgets are drivers of success and scale, rather than innovation. Innovation in mobile game is not impossible, but difficult to do, it was claimed. UA budgets can range from $50m+.

Chef Jon Sybert and his wife, Jill Tyler – alums of now-closed fine dining relics Komi and Little Serow – debuted Tail Up Goat in 2016, and went on to receive (and maintain) its star when the D.C.

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...